9:00 |
Welcome |
Rob Stockley, UK |
9:00-9:15 |
AIR Achievements |
Jan Stolk, Holland |
9:15-10:45 |
Session 1: Junior Research Session |
|
9:15-9:30 |
A genetic population screening of alpha-1antitrypsin deficiency in a high prevalence area of northern Italy. |
Bertella et al |
9:30-9:45 |
Serpin A1 gene variants in subjects from general population with reduced alpha 1-antitrypsin level. |
Zorzetto et al. |
9:45-10:00 |
Genetic influences upon respiratory phenotype in AATD. |
Wood et al. |
10:00-10:15 |
Differences in neutrophil migratory behaviour in COPD compared with age matched healthy controls and disease matched patients with Alpha 1 anti-trypsin deficiency. |
Sapey et al. |
10:15-10:30 |
A polymorphism of the alpha 1-antitrypsin gene represents a risk factor for liver disease. |
Chappell et al. |
10:30-10:45 |
To be confirmed |
|
10:45-11:15 |
Coffee and Poster Viewing |
|
11:15-12:30 |
Session2: Junior Research Session |
|
11:15-11:30 |
Inhaled corticosteroids as additional treatment in alpha1-antitrypsin deficiency-related COPD. |
La Piana et al. |
11:30-11:45 |
Outdoor air pollution relates to disease severity in AATD. |
Wood et al. |
11:45-12:00 |
Ventilation inhomogeneity is influenced by emphysema distribution in a1-antitripsin deficiency (AATD). |
Fregonese et al |
12:00-12:15 |
Serpin A1 is a potent inhibitor of IL-8-induced haemopoietic stem cell mobilization. |
Van Pel et al. |
12:15-12:30 |
To be confirmed |
|
12:30-13:00 |
Laurell Lecture |
Rob Stockley, UK |
13:00-14:00 |
Lunch |
|
14:00-15:30 |
Session 3: Senior Presentations – THERAPY |
|
14:00-14:15 |
EXACTLE results |
Prof Dirksen, Denmark |
14:15-14:30 |
Implications of the EXACTLE/Integrated Analysis |
Prof Stockley, UK |
14:30-15:00 |
Combined Discussion |
Profs Dirksen and Stockley |
15:00-15:30 |
Small Molecules |
Prof Lomas, UK |
15:30-16:00 |
Tea with Posters |
|
16:00-17:20 |
Session4: Senior Presentations |
|
16:00-16:20 |
Anti-inflammatory mechanisms of AAT |
Dr Janciauskiene, Sweden |
16:20-16:40 |
AATD Screening |
Prof Kalsheker, UK |
16:40-17:00 |
Sibling Study |
Prof Silverman, USA |
17:00-17:20 |
Swedish Cohort |
Dr Piitulainen, Sweden |
